UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer Journal article
Cao, Bihui, Liu, Manting, Wang, Lu, Zhu, Kangshun, Cai, Mingyue, Chen, Xiaopei, Feng, Yunfei, Yang, Shuo, Fu, Shengyu, Zhi, Cheng, Ye, Xiaodie, Zhang, Jian, Zhang, Zhiru, Yang, Xin, Zhao, Ming, Wu, Qingde, Xu, Linfeng, Yang, Lili, Lian, Hui, Zhao, Qi, Zhang, Zhenfeng. Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer[J]. Nature Communications, 2022, 13(1), 6203.
Authors:  Cao, Bihui;  Liu, Manting;  Wang, Lu;  Zhu, Kangshun;  Cai, Mingyue; et al.
Favorite | TC[WOS]:48 TC[Scopus]:48  IF:14.7/16.1 | Submit date:2023/01/30
Growth  Antibody  Thermal Ablation  Receptor Tyrosine Kinases  
Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy Journal article
Luo, Kaipei, Lian, Yunfei, Zhang, Min, Yu, Hua, Wang, Guangji, Li, Juan. Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy[J]. Chemical Engineering Journal, 2021, 412, 128659.
Authors:  Luo, Kaipei;  Lian, Yunfei;  Zhang, Min;  Yu, Hua;  Wang, Guangji; et al.
Favorite | TC[WOS]:25 TC[Scopus]:27  IF:13.3/13.2 | Submit date:2021/12/07
Charge Convertible Biomimetic Nanoparticle  Combined Chemoimmunotherapy  Ido Inhibition  Immunogenic Cell Death  M2-type Tumor-associated Macrophages  
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Other
2016-01-01
Authors:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai; et al.
Favorite | TC[WOS]:407 TC[Scopus]:24 | Submit date:2022/07/20